
Treatment With Schistosoma Japonicum Peptide SJMHE1 and SJMHE1-Loaded Hydrogel for the Mitigation of Psoriasis
Introduction Psoriasis is an immune-mediated, chronic inflammatory skin disease affecting approximately 3% of the global population, characterized by scaly erythematous patches. Its incidence is rising annually, with China’s rate increasing nearly fourfold …